Maxim Group analyst Anthony Vendetti maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $7 to $10.
Maxim Group Maintains Buy on Sensus Healthcare, Raises Price Target to $10
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.